We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Guidance for prescribing vets on the use of the cascade.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Guidance on the process for ending a clinical trial.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Explanation for animal owners and veterinary health professionals on how the VMD calculates adverse event incidence rates for veterinary medicines
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
As with all products, the MHRA will keep its safety under close review.
As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).